Exosome Characterization and Analytical Development Summit The Westin Boston Seaport District, Boston
In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera’s FDA IND approval to Brexogen’s recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements.
The Exosome Characterization and Analytical Development Summit offers a comprehensive forum, equipping you with the skills needed to establish robust techniques, select the best instruments, ensure quality, and seamlessly navigate regulatory processes.